Toxicological Sciences 55, 107-115 (2000)
Copyright © 2000 by the Society of Toxicology
In Vitro Toxicology and Alternative Testing |
Ah Receptor-Based Chemical Screening Bioassays: Application and Limitations for the Detection of Ah Receptor Agonists
Department of Environmental Toxicology, University of California, Davis, California 95616
The aromatic hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates many of the biologic and toxicologic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) and related chemicals. Here we utilized two AhR-dependent bioassay systems as screening tools to identify novel AhR agonists and to detect the presence of AhR agonists in sample extracts. These assays measure the ability of a chemical to activate AhR DNA binding in vitro (GRAB bioassay) or AhR-dependent (luciferase) gene expression in cultured cells (CALUX bioassay). Known AhR agonists (halogenated and nonhalogenated aromatic hydrocarbons) were positive in both assays, whereas the AhR antagonist 
-naphthoflavone exhibited agonist activity only in the GRAB assay. In vitro GRAB analysis has identified several imidazoline receptor ligands and ß-carbolines as AhR agonists and also revealed the presence of AhR agonist activity in crude DMSO extracts of commercial newspapers. In contrast to their positive activity in the GRAB assay, the majority of these chemicals/extracts were only weakly active or inactive in the cell-based CALUX assay. Our results not only reveal that the ability of a chemical to activate the AhR in vitro does not necessarily correlate with its ability to induce gene expression in intact cells, but the high level of false positives obtained with the GRAB assay clearly demonstrates its inability to accurately identify AhR agonists or agonist activity. Screening of unknown chemicals, chemical classes, and samples for AhR agonist activity will require the use of intact cell bioassays.
Key Words: Ah receptor; 2,3,7,8-tetrachlorodibenzo-p-dioxin; TCDD; CALUX; halogenated aromatic hydrocarbon; imidazoline.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. E. S. Bohonowych, B. Zhao, A. Timme-Laragy, D. Jung, R. T. Di Giulio, and M. S. Denison Newspapers and Newspaper Ink Contain Agonists for the Ah Receptor Toxicol. Sci., April 1, 2008; 102(2): 278 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chang, K.-w. Peng, I. Kastrati, C. R. Overk, Z.-H. Qin, P. Yao, J. L. Bolton, and G. R. J. Thatcher Activation of Estrogen Receptor-Mediated Gene Transcription by the Equine Estrogen Metabolite, 4-Methoxyequilenin, in Human Breast Cancer Cells Endocrinology, October 1, 2007; 148(10): 4793 - 4802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Korashy, A. Shayeganpour, D. R. Brocks, and A. O.S. El-Kadi Induction of Cytochrome P450 1A1 by Ketoconazole and Itraconazole but not Fluconazole in Murine and Human Hepatoma Cell Lines Toxicol. Sci., May 1, 2007; 97(1): 32 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Behnisch, K. Hosoe, A. Brouwer, and S.-i. Sakai Screening of Dioxin-Like Toxicity Equivalents for Various Matrices with Wildtype and Recombinant Rat Hepatoma H4IIE Cells Toxicol. Sci., September 1, 2002; 69(1): 125 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Andreasen, M. E. Hahn, W. Heideman, R. E. Peterson, and R. L. Tanguay The Zebrafish (Danio rerio) Aryl Hydrocarbon Receptor Type 1 Is a Novel Vertebrate Receptor Mol. Pharmacol., August 1, 2002; 62(2): 234 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Nagy, J. R. Sanborn, B. D. Hammock, and M. S. Denison Development of a Green Fluorescent Protein-Based Cell Bioassay for the Rapid and Inexpensive Detection and Characterization of Ah Receptor Agonists Toxicol. Sci., February 1, 2002; 65(2): 200 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-E. Lee and S. Safe 3',4'-Dimethoxyflavone as an Aryl Hydrocarbon Receptor Antagonist in Human Breast Cancer Cells Toxicol. Sci., December 1, 2000; 58(2): 235 - 242. [Abstract] [Full Text] [PDF]
|
|